In vitro toxic effects of certain antibiotics on the fibroblasts of two children with I-cell disease

Cell Biology and Toxicology

Volumn 14, Issue 5, 1998, Pages 333-343

  Dumontel, C ^a   Constant, H ^b   Souillet, G ^b   Zabot, M T ^b  

^a UNIVERSITÉ LYON 1   (France)

^b HÔPITAL DEBROUSSE   (France)

Author keywords

Antibiotics; Cultured fibroblasts; Cytotoxicity; I cell disease; Ultrastructure

Indexed keywords

CEFTAZIDIME; FOSFOMYCIN; LYSOSOME ENZYME; PEFLOXACIN; PIPERACILLIN; SPHINGOMYELIN PHOSPHODIESTERASE; TEICOPLANIN; VANCOMYCIN;

ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LIPID STORAGE; MUCOLIPIDOSIS TYPE 2; PRIORITY JOURNAL; SKIN FIBROBLAST;

ANTI-BACTERIAL AGENTS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; CHILD, PRESCHOOL; CHOLESTEROL; FIBROBLASTS; HUMANS; MALE; MICROSCOPY, ELECTRON; MUCOLIPIDOSES; SKIN; SPHINGOMYELIN PHOSPHODIESTERASE;

EID: 0031712815     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007533723782     Document Type: Article

References (21)

1. Bergogne-Berezin E. Relation structure-activité de la ceftazidime. Conséquence sur le spectre bactérien. Presse Med. 1988;17:1878-82.
2. Cogen RB, Taubmann JB. Cellular effects on human leucocyte hydrolases. I. Human gingival fibroblasts. J Oral Pathol. 1982a; 11:290-9.
3. Cogen RB, Taubman SB, Goldblatt PJ. Cellular effects of human leucocyte hydrolases. II. Ultrastructural studies on fibroblasts. J Oral Pathol. 1982b;11:300-9.
4. Duval J. Classification et mécanisme d'action des agents antibactériens. In: Le Minor L, Veron M, eds. Bactériologie Médicale. Paris: Flammarion; 1989:273-96.
5. Drugeon HB, Caillon J, Dellamonica P. Etude des antibiotiques: les cinétiques de bactéricidie. J Pharm Clin. 1988;7:25-8.
6. Greenwood D. Propriétés microbiologiques de la teicoplanine. J Antimicrob Chemother. 1988;21(supplement A):1-13.
7. Kacew S, Hewitt WR, Hook JB. Gentamicin-induced renal metabolic alterations in newborn rat kidney: lack of potentiation by vancomycin. Toxicol Applied Pharmacol. 1989;99:61-71.
8. Lüllmann-Rauch R. Drug induced lysosomal storage disorders. Frontiers Biol. 1979;48:49-130.
9. Marre R, Schultz E, Hedtke D, Sack K. Influence of fosfomycin and tobramycin on vancomycin-induced nephrotoxicity. Infection. 1985;13:38-40.
10. Maurin R, Raoult D. Antibiotic penetration within eukaryotic cells. In: Raoult D, ed. Antimicrobial agents and intracellular pathogens. Boca Raton: CRC Press; 1993:23-37.
11. Neufeld EF, McKusick VA. Disorders of lysosomal enzyme synthesis and localization: I-cell disease and pseudo-Hurler polydystrophy. In: Stanbury JB, ed. The metabolic basis of inherited diseases. New York: McGraw-Hill; 1983:778-87.
12. Panteix G. Etablissement d'un modèle d'étude de la pénétration intraphagocytaire et intrapulmonaire d'agents antibiotiques. Thèse de Doctorat, Lyon; 1992.
13. Parenti F. Structure and mechanism of action of teicoplanin. J Hosp Infect. 1986;7:79-83.
14. Pechere JC, Dugal R. Clinical pharmacokinetics of aminoglycoside antibiotics. Clin Pharmacokinet. 1979;4:170-99.
15. Pierre C, Blanchet F, Seta N et al. Tolerance of once daily dosing of netilmicin and teicoplanin, alone or in combination, in healthy volunteers. Clin Pharmacol Ther. 1988;44:458-66.
16. Pryka RD, Rodvold KA, Rothschafer JC. Teicoplanin: an investigational glycopeptide antibiotic. Clin Pharmacol. 1988;7:647-58.
17. Reynolds PE. Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis. 1989;8:943-50.
18. Somma S, Gastaldo L, Corti A. Teicoplanin, a new antibiotic from Actinoplanes teichomyceticus. Antimicrob Agents Chemother. 1984;26:917-23.
19. Vanier MT, Revol A, Pichet M. Sphingomyelinase activities of various human tissues in control subjects and in Niemann-Pick disease. Development and evaluation of a microprocedure. Clin Chim Acta. 1980;106:257-67.
20. Vanier MT, Rodriguez-Lafrasse C, Rousson R et al. Type C Niemann-Pick disease: spectrum of phenotypic variation in disruption of intracellular LDL-derived cholesterol processing. Biochim Biophys Acta. 1991;1096:328-37.
21. Vanier MT, Rodriguez-Lafrasse C, Rousson R et al. Prenatal diagnosis of Niemann-Pick type C disease: current strategy from an experience of 37 pregnancies at risk. Am J Hum Genet. 1992;51:111-22.